comparemela.com

Latest Breaking News On - Refractive surgery annual meeting - Page 1 : comparemela.com

Eyenovia, Inc (NASDAQ:EYEN) Q1 2024 Earnings Call Transcript

Eyenovia, Inc (NASDAQ:EYEN) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesRedwood citySouth koreaMatthew kaplanMichael roweMatthew caufieldMatt kaplanOrasis pharmaKemp dolliverBren kernEric ribnerBrian kemp dolliverBrent kernEyenovia optejetJohn gandolfoVision source exchange in orlando

Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript

Bausch + Lomb Corporation misses on earnings expectations. Reported EPS is $0.07 EPS, expectations were $0.09.

United statesSam eldessoukyPatrick woodGeorge gadkowskiBrent saundersRobbie marcusLarry biegelsenJoanne wuenschOsama eldessoukyYoung liMorgan stanleyBausch lomb corpLomb corporationWells fargoAmerican society of cataractCall transcript may

STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024

Scientific content at ASCRS related to EVO ICL™ doubles with 44 posters and presentations STAAR is leading a comprehensive clinical education program including a lunch symposium, multiple.

Switzerland generalUnited statesLake forestTom frinziJ morgan michelettiAliso viejoTaj nasserUs based single center studySurgical companyAffairs information deskClinical affairs resourcesAmerican society of cataractAmerican societyRefractive surgery annual meetingBusiness wireEducational programming

FDA clears Lensar Ally cataract treatment system

Lensar announced today that it received FDA 510(k) clearance for its next-generation Ally system.

United statesNick curtisAmerican society of cataractFlorida based lensarRally systemAmerican societyRefractive surgery annual meeting

LENSAR : reg; Receives U S FDA Clearance of ALLY™ Adaptive Cataract Treatment System - Form 8-K

LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System June 13, 2022, ORLANDO, Fla. LENSAR, Inc. , a global medical technology company. | June 13, 2022

United statesDburns mcclellanThomasr staabLauren gyoerkoeLee roth cameron radinovicNick curtisAmerican society of cataractExchange commissionLensar incSecurities exchangeDrug administrationCompany quarterly report on formAdaptive cataract treatment systemCataract treatment systemAmerican societyRefractive surgery annual meeting

vimarsana © 2020. All Rights Reserved.